News Archives | Beat Childhood Cancer

Penn State College of Medicine, Beat Childhood Cancer Research Consortium and Four Diamonds launch clinical trial that aims to combat solid tumors

Penn State College of Medicine, Beat Childhood Cancer Research Consortium and Four Diamonds launch clinical trial that aims to combat solid tumors

Jessica Bumpus2024-09-30T13:23:27-04:00September 30th, 2024|

In a step toward fighting solid tumors in children and young adults, Penn State College of Medicine, the Beat Childhood Cancer Research Consortium and Four Diamonds, along with Senhwa Biosciences, Inc. are launching a pioneering clinical trial. The study aims to evaluate the investigational drug, silmitasertib, in combination with FDA-approved drugs for solid tumors. This innovative trial seeks to establish a [...]

Q&A: Finding novel therapies for childhood cancer

Q&A: Finding novel therapies for childhood cancer

Jessica Bumpus2024-08-14T14:28:21-04:00August 14th, 2024|

Since the first time she treated a child with neuroblastoma, Giselle Saulnier Sholler wanted to do the impossible for her patients. Neuroblastoma is the most common extracranial solid tumor in children with roughly 700 new diagnoses every year. The survival rate is 30% and for patients who relapse following conventional standard of care treatments, the survival rate [...]

FDA approves pediatric neuroblastoma drug based on Penn State professor’s work

FDA approves pediatric neuroblastoma drug based on Penn State professor’s work

Jessica Bumpus2023-12-15T08:07:56-05:00December 15th, 2023|

Giselle Saulnier Sholler, professor of pediatrics and of pharmacology, reflects on 20 years working to change cancer outcomes for children HERSHEY, Pa. — In 2003, the first year of her fellowship in pediatric oncology, two of Giselle Saulnier Sholler’s first three patients had died from neuroblastoma, closely matching the 30% survival rate expected at the [...]

US WorldMeds Announces FDA Approval of IWILFIN™ (eflornithine) to Strengthen Fight Against Aggressive Childhood Cancer

US WorldMeds Announces FDA Approval of IWILFIN™ (eflornithine) to Strengthen Fight Against Aggressive Childhood Cancer

Jessica Bumpus2023-12-15T08:08:24-05:00December 15th, 2023|

LOUISVILLE, Ky.--(BUSINESS WIRE)--USWM, LLC (US WorldMeds) today announced that the U.S. Food and Drug Administration (FDA) has approved IWILFIN™ (eflornithine) 192 mg tablets, a groundbreaking oral maintenance therapy for high-risk neuroblastoma. IWILFIN is indicated to reduce the risk of relapse in adult and pediatric patients with high-risk neuroblastoma who have demonstrated at least a partial [...]

Penn State Health recruits leading researcher to fight pediatric cancer

Penn State Health recruits leading researcher to fight pediatric cancer

Jessica Bumpus2023-08-08T10:20:09-04:00August 8th, 2023|

Cris Collingwood//August 2, 2023 An internationally known physician-scientist and her research consortium have joined Penn State Health to continue efforts to eradicate pediatric cancer. Penn State Health and Penn State College of Medicine said Dr. Giselle Saulnier Sholler and her research team will be on board Sept. 1 to provide greater access to pediatric care and research, including [...]

The Power of Will

The Power of Will

Jessica Bumpus2023-08-08T10:22:34-04:00December 8th, 2016|

Will Lacey was just a baby when doctors diagnosed a rare form of cancer and told his family there was only one end. Nobody then could imagine the journey ahead, from hospital rooms to board rooms, research labs to government offices, a furious race between hope and death. WRITTEN BY BILLY BAKERILLUSTRATED BY TONIA COWAN Boston [...]

Michigan Child Trials Target Genetic Roots of Cancers

Michigan Child Trials Target Genetic Roots of Cancers

Beat Childhood Cancer2023-07-06T10:35:27-04:00April 15th, 2015|

Thank you Detroit News for featuring a story about the work we are doing. It wouldn’t be possible without the support of Dell, TGen Foundation and our generous community. Together, we can change and save lives.‪#‎EndChildhoodCancer‬

Feasibility of Implementing Molecular-guided Therapy for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

Feasibility of Implementing Molecular-guided Therapy for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

Beat Childhood Cancer2023-07-06T10:36:07-04:00March 12th, 2015|

DOWNLOAD THE FULL ARTICLE (PDF).

$1,100,000 for Beat Childhood Cancer Research!

$1,100,000 for Beat Childhood Cancer Research!

Beat Childhood Cancer2023-07-06T10:36:35-04:00February 12th, 2015|

On December 24, 2014 the Grand Rapids community surpassed the Million Dollar Challenge by raising $1,100,000 for NMTRC research! This donation was then matched by a generous Beat NB donor from Boston. This week we were honored to have Patrick Lacey at Helen DeVos Children’s Hospital to present a check for $1,100,000 to match what [...]

Endowment Gift Establishes Haworth Family Pediatric Oncology Innovative Therapeutics Clinic at Helen Devos Children’s Hospital

Endowment Gift Establishes Haworth Family Pediatric Oncology Innovative Therapeutics Clinic at Helen Devos Children’s Hospital

Beat Childhood Cancer2023-08-28T10:16:20-04:00July 5th, 2013|

Children fighting cancer have new hope thanks to an endowment gift from Dick and Ethie Haworth to the Helen DeVos Children’s Hospital Foundation. Their major gift establishes the Haworth Family Pediatric Oncology Innovative Therapeutics Clinic at Helen DeVos Children’s Hospital. The gift will support an endowed directorship held by nationally recognized Giselle Sholler, MD, in [...]